What is the recommended treatment for an adult with seasonal allergic rhinitis (hay fever)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Treatment for Adult Hay Fever

For adults with seasonal allergic rhinitis (hay fever), start with an intranasal corticosteroid (such as fluticasone, mometasone, or budesonide) as monotherapy—this is the single most effective first-line treatment. 1

Treatment Algorithm

First-Line Treatment: Intranasal Corticosteroid Monotherapy

The 2017 Joint Task Force on Practice Parameters provides strong evidence-based recommendations that intranasal corticosteroids should be prescribed as initial monotherapy rather than combination therapy with oral antihistamines 1. This represents a strong recommendation based on moderate-quality evidence using GRADE methodology.

Key points:

  • Intranasal corticosteroids are superior to oral antihistamines, leukotriene receptor antagonists (like montelukast), and intranasal antihistamines when used alone
  • Common options include fluticasone propionate, mometasone, budesonide, and triamcinolone—many now available over-the-counter
  • These work through anti-inflammatory mechanisms and reduce mediator release, making them particularly effective for nasal congestion 2

When NOT to Add Oral Antihistamines Initially

Do not routinely add oral antihistamines to intranasal corticosteroids for initial treatment 1. The evidence shows no meaningful additional benefit from this combination, despite it being commonly practiced. This is a strong recommendation against combination therapy with oral antihistamines at the outset.

Second-Line: Escalation for Moderate-to-Severe Disease

If symptoms are moderate to severe and inadequately controlled with intranasal corticosteroid monotherapy, consider adding an intranasal antihistamine (azelastine or olopatadine) to the intranasal corticosteroid 1. This is a weak recommendation, meaning it's appropriate for many but not all patients.

The combination of intranasal corticosteroid plus intranasal antihistamine (not oral) showed:

  • Symptom score reductions of approximately 5.3-5.7 points (on a 24-point scale) versus 3.8-5.1 for intranasal corticosteroid alone
  • Greater than 40% relative improvement compared to monotherapy 1
  • Most effective for patients with baseline symptom scores indicating moderate-to-severe disease

Important caveat: This combination carries increased risk of dysgeusia (altered taste, 2-13% of patients) and potential somnolence 1.

Alternative Options (Less Preferred)

Leukotriene receptor antagonists (montelukast): Intranasal corticosteroids are definitively superior to montelukast for symptom control 1. This is a strong recommendation based on high-quality evidence. Reserve montelukast for:

  • Patients who refuse or cannot tolerate intranasal medications
  • Concurrent mild persistent asthma (though still not preferred for either condition alone) 1

Oral antihistamines alone: Less effective than intranasal corticosteroids but reasonable for mild intermittent symptoms. Second-generation agents (cetirizine, fexofenadine, loratadine, desloratadine) avoid sedation 3.

Common Pitfalls to Avoid

  1. Don't start with combination therapy: The evidence clearly shows intranasal corticosteroid monotherapy should be tried first 1

  2. Don't use long-acting intramuscular steroids: These carry increased risk of systemic adverse effects without clear benefit 4

  3. Don't use topical vasoconstrictors long-term: Risk of rebound congestion and other side effects with prolonged use 2

  4. Don't add oral antihistamines reflexively: No benefit when added to intranasal corticosteroids initially 1

Severity-Based Approach

Mild intermittent symptoms (< 4 days/week or < 4 weeks/year):

  • Second-generation oral antihistamine OR intranasal antihistamine alone may suffice 3

Persistent moderate-to-severe symptoms (> 4 days/week AND > 4 weeks/year):

  • Start with intranasal corticosteroid monotherapy
  • If inadequate response, add intranasal antihistamine (not oral) 3

Additional Considerations

Allergen immunotherapy (subcutaneous or sublingual) is the only disease-modifying treatment and should be considered for patients with inadequate response to optimal pharmacotherapy 1. However, this is beyond initial pharmacologic management.

Sodium cromoglicate has documented efficacy with minimal adverse effects but is less effective than intranasal corticosteroids 4.

The evidence strongly supports a stepwise approach starting with intranasal corticosteroid monotherapy, with escalation to combination therapy with intranasal (not oral) antihistamines reserved for inadequate initial response in moderate-to-severe disease.

References

Related Questions

What is the appropriate management of severe persistent allergic rhinitis with nasal congestion in an 83-year-old male with coronary artery disease?
What prescription and non‑pharmacologic alternatives can be used to treat seasonal allergic rhinitis in a healthy adult who wants to avoid over‑the‑counter medications?
What is the recommended treatment for chest tightness and mild dyspnea associated with seasonal allergic rhinitis?
Is it safe for a 10-year-old child to take Claritin (loratadine) and, a few hours later, Zyrtec (cetirizine) for allergic rhinitis symptoms such as sneezing, rhinorrhea, and watery eyes?
What is the likely cause of sneezing after meals (gustatory rhinitis) and how should it be evaluated and managed?
Why would an intubated patient receiving only dexmedetomidine have absent rectal tone?
What is the typical clinical presentation of an ulnar nerve injury?
What is the recommended management for a facial dog bite, including wound irrigation, antibiotic prophylaxis, tetanus and rabies prophylaxis, closure considerations, imaging for deep structures, and follow‑up care?
Should I take Eliquis (apixaban) while intoxicated with alcohol?
In an institutionalized patient already on multiple antipsychotics for aggressive behavior, what non‑benzodiazepine, non‑antipsychotic medication can be used to manage anger?
What is the appropriate management for a female patient hospitalized with acute respiratory failure who had a resolved mixed cardiogenic shock and presented with moderate diabetic ketoacidosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.